Page last updated: 2024-08-17

quinoxalines and Porphyria Cutanea Tarda

quinoxalines has been researched along with Porphyria Cutanea Tarda in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chaparro, M; García-Buey, L; Rojo, E	1
Seetharam, A; Sehmbey, G	1

Other Studies

2 other study(ies) available for quinoxalines and Porphyria Cutanea Tarda

Article	Year
Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease. Journal of Crohn's & colitis, 2020, May-21, Volume: 14, Issue:4 Topics: Aminoisobutyric Acids; Antibodies, Monoclonal, Humanized; Benzimidazoles; Crohn Disease; Cyclopropanes; Gastrointestinal Agents; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Pyrrolidines; Quinoxalines; Sulfonamides	2020
Porphyria Cutanea Tarda Improvement With Elbasvir/Grazoprevir in End-Stage Renal Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:10 Topics: Antiviral Agents; Benzofurans; Drug Combinations; Female; Hand Dermatoses; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Liver Cirrhosis; Middle Aged; Porphyria Cutanea Tarda; Porphyrins; Quinoxalines; Sustained Virologic Response; Viral Load	2019

Article

Year

Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease.

Journal of Crohn's & colitis, 2020, May-21, Volume: 14, Issue:4

Topics: Aminoisobutyric Acids; Antibodies, Monoclonal, Humanized; Benzimidazoles; Crohn Disease; Cyclopropanes; Gastrointestinal Agents; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Pyrrolidines; Quinoxalines; Sulfonamides

2020

Porphyria Cutanea Tarda Improvement With Elbasvir/Grazoprevir in End-Stage Renal Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:10

Topics: Antiviral Agents; Benzofurans; Drug Combinations; Female; Hand Dermatoses; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Liver Cirrhosis; Middle Aged; Porphyria Cutanea Tarda; Porphyrins; Quinoxalines; Sustained Virologic Response; Viral Load

2019